Clinical trial

Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate…

NCT00243048 · Barbara Ann Karmanos Cancer Institute, Other · Completed

Key facts

NCT number NCT00243048
Title Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer
Official title Phase II Randomized Study of Soy Isoflavones in Patients With Localized Prostate Cancer Treated With Radiation Therapy
Lead sponsor Barbara Ann Karmanos Cancer Institute, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Prostate Cancer
Intervention type Dietary Supplement, Radiation
Interventions soy protein isolate, radiation therapy
Enrollment 70
Start date May 1, 2002
Primary completion Oct 1, 2006
Completion Oct 1, 2007
First posted Oct 21, 2005
Last update posted Apr 5, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies